Evidence map›Paper›PMID 28248553›Full record

ArticleAmerican journal of respiratory cell and molecular biology2017

Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.

Agnieszka P Looney, Rong Han, Lukasz Stawski, Grace Marden, Masahiro Iwamoto, Maria Trojanowska

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Transcriptional regulation in cardiovascular aging.Frontiers in cardiovascular medicine · 2026
    Review
  6. Targeting endothelial ERG to mitigate vascular regression in retinopathies.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. EndothelialResearch square · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. The Expression of Proto-OncogeneInternational journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Agnieszka P Looney1 Boston University School of Medicine, Arthritis Center/Rheumatology, Boston, Massachusetts; and.
Rong Han1 Boston University School of Medicine, Arthritis Center/Rheumatology, Boston, Massachusetts; and.
Lukasz Stawski1 Boston University School of Medicine, Arthritis Center/Rheumatology, Boston, Massachusetts; and.
Grace Marden1 Boston University School of Medicine, Arthritis Center/Rheumatology, Boston, Massachusetts; and.
Masahiro Iwamoto2 Orthopaedic Research, The Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania.
Maria Trojanowska1 Boston University School of Medicine, Arthritis Center/Rheumatology, Boston, Massachusetts; and.ORCID 0000-0001-9550-7178
Boston University · USChildren's Hospital of Philadelphia · US

Funding

Boston University Clinical and Translational Science Award (CTSA) Program UL1UL1TR000157 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2012 to 2013
$7.9M
The molecular mechanisms of fibrosisR01AR042334 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TROJANOWSKA, MARIA · 1994 to 2018
$5.2M
TRANSCRIPTION FACTOR ERG AND SKELETOGENESISR01AR046000 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI IWAMOTO, MASAHIRO, PACIFICI, MAURIZIO · 1999 to 2016
$4.8M
Rheumatic Diseases Research Core CentersP30AR061271 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WHITFIELD, MICHAEL L · 2011 to 2015
$3.1M
NCATS NIH HHS UL1 TR000157NIAMS NIH HHS P30 AR061271NIAMS NIH HHS R01 AR042334NIAMS NIH HHS R01 AR046000
6 · The paper itself

Abstract

Endothelial cell (EC) activation underlies many vascular diseases, including pulmonary arterial hypertension (PAH). Several members of the E-twenty six (ETS) family of transcription factors are important regulators of the gene network governing endothelial homeostasis, and their aberrant expression is associated with pathological angiogenesis. The goal of this study was to determine whether deficiencies of the ETS family member, Friend leukemia integration 1 transcription factor (FLI1), and its closest homolog, ETS-related gene (ERG), are associated with PAH. We found that endothelial ERG was significantly reduced in the lung samples from patients with PAH, as well as in chronically hypoxic mice. Functional studies revealed that depletion of ERG or FLI1 in human pulmonary ECs led to increased expression of inflammatory genes, including IFN genes, whereas genes regulating endothelial homeostasis and cell-cell adhesion were down-regulated. Simultaneous knockdown of both ERG and FLI1 had synergistic or additive effects on the expression of these genes, suggesting that ERG and FLI1 coregulate at least a subset of their target genes. Functionally, knockdown of ERG and FLI1 induced cell monolayer permeability with a potency similar to that of vascular endothelial growth factor. Notably, stimulation of ECs with Toll-like receptor 3 ligand poly(I:C) suppressed ERG expression and induced ERG dissociation from the IFNB1 promoter, while promoting signal transducers and activators of transcription 1 (STAT1) recruitment. Consistent with the up-regulation of inflammatory genes seen in vitro, Erg and Fli1 double-heterozygote mice showed increased immune cell infiltration and expression of cytokines in the lung. In conclusion, loss of ERG and FLI1 might contribute to the pathogenesis of vascular lung complications through the induction of inflammation.

Indexed as

HomeostasisAnimalsChronic DiseaseDown-RegulationEndothelium, VascularFemaleHeterozygoteHumansHypertension, PulmonaryHypoxiaInterferon-betaLungMaleMice, Inbred C57BLOncogene ProteinsPneumoniaERG protein, humanERG protein, mouseInterferon-betaOncogene ProteinsPoly I-CProto-Oncogene Protein c-fli-1STAT1 Transcription FactorTranscriptional Regulator ERGE–twenty six–related geneFriend leukemia integration 1 transcription factorIFNpulmonary arterial hypertensionsystemic sclerosis

Identifiers

PMID28248553
PMCPMC5516275
OpenAlexW2594169722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.